Determinants of functional outcome and healthcare costs in bipolar disorder: a high-intensity follow-up study.
about
The International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 4: Unmet Needs in the Treatment of Bipolar Disorder and Recommendations for Future ResearchThe Relationship Between Neurocognitive Functioning and Occupational Functioning in Bipolar Disorder: A Literature ReviewOverall well-being as a predictor of health care, productivity, and retention outcomes in a large employerThe functional impact of subsyndromal depressive symptoms in bipolar disorder: data from STEP-BD.The relationship between religious involvement and clinical status of patients with bipolar disorderRESEARCH: Cognitive rehabilitation for bipolar disorder: An open trial for employed patients with residual depressive symptoms.Brief depressive symptoms in patients with bipolar disorder: analysis of long-term self-reported data.Implementing composite quality metrics for bipolar disorder: towards a more comprehensive approach to quality measurementDifferences in demographic composition and in work, social, and functional limitations among the populations with unipolar depression and bipolar disorder: results from a nationally representative samplePharmacotherapy for bipolar depression: an economic assessment.Mood disorder symptoms and elevated cardiovascular disease risk in patients with bipolar disorder.The phenomenology of bipolar disorder: what drives the high rate of medical burden and determines long-term prognosis?Impact of bipolar disorder: results from a screening study.Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workersBipolar depression: phenomenological overview and clinical characteristics.Randomized, placebo-controlled, adjunctive study of armodafinil for bipolar I depression: implications of novel drug design and heterogeneity of concurrent bipolar maintenance treatments.Treatment of bipolar depression: focus on pharmacologic therapies.Treatment and outcomes of an Australian cohort of outpatients with bipolar I or schizoaffective disorder over twenty-four months: implications for clinical practice.Emerging drugs for bipolar disorder.Long-term social functioning after depression treated by psychiatrists: a review.Determinants of occupational and residential functioning in bipolar disorder.Management of bipolar disorder in the intercontinental region: an international, multicenter, non-interventional, cross-sectional study in real-life conditions.Factors associated with functional recovery in bipolar disorder patients.The prevalence and correlates of workplace depression in the national comorbidity survey replication.Recovery from multiple episodes of bipolar I depression.Personality pathology predicts outcomes in a treatment-seeking sample with bipolar I disorder.[Factors predicting functioning in type 1 bipolar patients during remission period].Metabolic syndrome and bipolar disorder: what should psychiatrists know?The association of bipolar spectrum disorders and borderline personality disorder.Short- and long-term relationships between neurocognitive performance and general function in bipolar disorder.Phenomenological predictors of psychosocial function in bipolar disorder: is there evidence that social cognitive and emotion regulation abnormalities contribute?A review on the impact of cognitive dysfunction on social, occupational, and general functional outcomes in bipolar disorder.Functional impairment as a predictor of short-term symptom course in bipolar I disorder.Demographic and diagnostic characteristics of the first 1000 patients enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).Residual symptoms and specific functional impairments in euthymic patients with bipolar disorder.Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression.Lithium treatment -- moderate dose use study (LiTMUS) for bipolar disorder: rationale and design.Quality of life in bipolar type I disorder in a one-year followup.Impulsivity predicts time to reach euthymia in adults with bipolar disorder.Adjunctive stimulant use in patients with bipolar disorder: treatment of residual depression and sedation.
P2860
Q28072601-E296F90A-73C9-427B-BFF1-1B62B5F8777FQ28075330-A715C483-E404-4B62-8EB3-81AADBAF5C42Q28393217-F779286A-DCFC-48D8-8A31-BAB07CC81AD8Q31171961-AD98F7B1-B33D-4AE1-853E-8CA987692F77Q33786604-4C60C501-9F05-4755-9D85-AFFD69FCF7BAQ33925317-99E83837-4AD5-4FD4-B083-A43284AE9D34Q34317237-8DE1D728-86AD-4422-A865-ABF115E73F79Q34905003-B098CDB6-ABD9-4F3D-B90D-6E2E1CDB9363Q35520688-955D79B5-F72C-4707-BDAF-387489181F0AQ35779207-4E50EA4F-8231-4095-8B6D-C276221E4CF8Q35836912-50091AB7-1581-40D2-9B3D-C27F33B4D860Q35841353-038214B9-8D36-49AB-BD23-897D66DB9824Q35847010-DEA4F7EF-EF43-4DBB-BE6D-40B8338B3105Q35901587-5CC170F8-8958-4F0C-B8DD-5C2D8294789FQ35947340-3369A8A4-48E6-4130-9FBE-89B80E6C8299Q36017024-E5C3F4E6-6A14-4A9F-8E8A-2DC1E3A4D6B5Q36106769-B3C7AD8D-2361-4076-82BA-9A1E97B281E0Q36604329-29D64464-B2B1-4958-8BF9-AEB962C2B22EQ36634257-F40B00E6-D638-4F3E-9C64-26F1D778AF9DQ36772958-893AB33F-6DD4-4045-BF10-D14A79869681Q36803077-C7F68078-5C24-422B-85D5-8838AB1E0D23Q36902757-E4AFC06D-61B8-4763-9B2D-2662721CA5C9Q37109808-AAE28DB8-BD8E-44D5-8EBA-B02ECDB02563Q37135244-BD9C0DDE-761A-4AE6-A7AF-C5D5C804E3CAQ37334911-70B32B90-E69B-4A05-8C38-29228CD08F6EQ37542668-19EE1386-2D77-41FD-AE4C-F2377E8DBA8FQ37663233-E1BB07D1-52CA-4308-88F0-1E617849A235Q37954425-7584D6D4-1038-4354-B5DA-6F3C185AFEC8Q37990844-75B43F81-B160-4EF3-977E-2839CA4655E2Q38128856-D6B25C2D-E015-4FD2-9E43-64037000B940Q38152654-A555D376-7D8B-42DB-9BF9-8921B94DEB70Q38674810-BB37FABF-7CFC-4E03-B9D3-A585D8184084Q40104223-3995C960-A14E-42F9-833F-430F7BC76FEFQ40468543-44E4D689-7599-4770-BB57-8CF4BAA5DD49Q40869832-E3BF3811-C1A0-46A4-822F-6FB681EAF68FQ41981996-350EF0D8-ECF4-4F79-9DC3-CA3E8FC1EE9FQ42640514-8B5B9E8E-C98F-4443-87E1-3C3572A3F008Q42719937-DC3A421D-63C6-4E6C-B215-DC3ADD3CA640Q43631636-7D7FDBD0-1DB2-4E39-BB46-49FB2F2280B8Q44452755-8C9E1702-1607-4D64-BCFF-2D8E12D19532
P2860
Determinants of functional outcome and healthcare costs in bipolar disorder: a high-intensity follow-up study.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Determinants of functional out ...... igh-intensity follow-up study.
@ast
Determinants of functional out ...... igh-intensity follow-up study.
@en
Determinants of functional out ...... igh-intensity follow-up study.
@nl
type
label
Determinants of functional out ...... igh-intensity follow-up study.
@ast
Determinants of functional out ...... igh-intensity follow-up study.
@en
Determinants of functional out ...... igh-intensity follow-up study.
@nl
prefLabel
Determinants of functional out ...... igh-intensity follow-up study.
@ast
Determinants of functional out ...... igh-intensity follow-up study.
@en
Determinants of functional out ...... igh-intensity follow-up study.
@nl
P2093
P1476
Determinants of functional out ...... igh-intensity follow-up study.
@en
P2093
P304
P356
10.1016/S0165-0327(00)00247-0
P577
2001-08-01T00:00:00Z